Synthesis, Theoretical, in Silico and in Vitro Biological Evaluation Studies of New Thiosemicarbazones as Enzyme Inhibitors
Özet
Eleven new thiosemicarbazone derivatives (1–11) were designed from nine different biologically and pharmacologically important isothiocyanate derivatives containing functional groups such as fluorine, chlorine, methoxy, methyl, and nitro at various positions of the phenyl ring, in addition to the benzyl unit in the molecular skeletal structure. First, their substituted-thiosemicarbazide derivatives were synthesized from the treatment of isothiocyanate with hydrazine to synthesize the designed compounds. Through a one-step easy synthesis and an eco-friendly process, the designed compounds were synthesized with yields of up to 95 % from the treatment of the thiosemicarbazides with aldehyde derivatives having methoxy and hydroxy groups. The structures of the synthesized molecules were elucidated with elemental analysis and FT–IR, 1H-NMR, and 13C-NMR spectroscopic methods. The electronic and spectroscopic properties of the compounds were determined by the DFT calculations performed at the B3LYP/6-311++G(2d,2p) level of theory, and the experimental findings were supported. The effects of some global reactivity parameters and nucleophilic-electrophilic attack abilities of the compounds on the enzyme inhibition properties were also investigated. They exhibited a highly potent inhibition effect on acetylcholinesterase (AChE) and carbonic anhydrases (hCAs) (KI values are in the range of 23.54±4.34 to 185.90±26.16 nM, 103.90±23.49 to 325.90±77.99 nM, and 86.15±18.58 to 287.70±43.09 nM for AChE, hCA I, and hCA II, respectively). Furthermore, molecular docking simulations were performed to explain each enzyme-ligand complex's interaction. © 2023 Wiley-VHCA AG, Zurich, Switzerland.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Erdoğan, Musa | |
| dc.contributor.author | Serdar Çavuş, M. | |
| dc.contributor.author | Muğlu, Halit | |
| dc.contributor.author | Yakan, Hasan | |
| dc.contributor.author | Türkeş, Cüneyt | |
| dc.contributor.author | Demir, Yeliz | |
| dc.contributor.author | Beydemir, Şükrü | |
| dc.date.accessioned | 2026-10-18T20:26:51.737265265Z | |
| dc.date.available | 2026-10-18T20:26:51.737265265Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Eleven new thiosemicarbazone derivatives (1–11) were designed from nine different biologically and pharmacologically important isothiocyanate derivatives containing functional groups such as fluorine, chlorine, methoxy, methyl, and nitro at various positions of the phenyl ring, in addition to the benzyl unit in the molecular skeletal structure. First, their substituted-thiosemicarbazide derivatives were synthesized from the treatment of isothiocyanate with hydrazine to synthesize the designed compounds. Through a one-step easy synthesis and an eco-friendly process, the designed compounds were synthesized with yields of up to 95 % from the treatment of the thiosemicarbazides with aldehyde derivatives having methoxy and hydroxy groups. The structures of the synthesized molecules were elucidated with elemental analysis and FT–IR, 1H-NMR, and 13C-NMR spectroscopic methods. The electronic and spectroscopic properties of the compounds were determined by the DFT calculations performed at the B3LYP/6-311++G(2d,2p) level of theory, and the experimental findings were supported. The effects of some global reactivity parameters and nucleophilic-electrophilic attack abilities of the compounds on the enzyme inhibition properties were also investigated. They exhibited a highly potent inhibition effect on acetylcholinesterase (AChE) and carbonic anhydrases (hCAs) (KI values are in the range of 23.54±4.34 to 185.90±26.16 nM, 103.90±23.49 to 325.90±77.99 nM, and 86.15±18.58 to 287.70±43.09 nM for AChE, hCA I, and hCA II, respectively). Furthermore, molecular docking simulations were performed to explain each enzyme-ligand complex's interaction. © 2023 Wiley-VHCA AG, Zurich, Switzerland. | |
| dc.description.sponsorship | Funding text 1: This work was supported by the Research Fund of Anadolu University (grant number 2102 S003). The DFT calculations reported in this article were partially performed at TUBITAK ULAKBIM, High Performance and Grid Computing Center (TRUBA resources). ; Funding text 2: This work was supported by the Research Fund of Anadolu University (grant number 2102 S003). The DFT calculations reported in this article were partially performed at TUBITAK ULAKBIM, High Performance and Grid Computing Center (TRUBA resources). | |
| dc.identifier.doi | 10.1002/cbdv.202301063 | |
| dc.identifier.issn | 1612-1872 | |
| dc.identifier.issue | 11 | |
| dc.identifier.pmid | 37769192 | |
| dc.identifier.scopus | 2-s2.0-85174602710 | |
| dc.identifier.startpage | e202301063 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/11870 | |
| dc.identifier.volume | 20 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.ispartof | Chemistry and Biodiversity | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | DFT | |
| dc.subject | enzyme inhibition | |
| dc.subject | molecular docking | |
| dc.subject | structure characterization | |
| dc.subject | thiosemicarbazones | |
| dc.subject | acetylcholinesterase | |
| dc.subject | aldehyde derivative | |
| dc.subject | carbonate dehydratase I | |
| dc.subject | carbonate dehydratase II | |
| dc.subject | carbonate dehydratase inhibitor | |
| dc.subject | chlorine | |
| dc.subject | cholinesterase inhibitor | |
| dc.subject | fluorine | |
| dc.subject | glyceryl trinitrate | |
| dc.subject | hydrazine | |
| dc.subject | hydroxyl group | |
| dc.subject | isothiocyanic acid | |
| dc.subject | isothiocyanic acid derivative | |
| dc.subject | thiosemicarbazide derivative | |
| dc.subject | Article | |
| dc.subject | carbon nuclear magnetic resonance | |
| dc.subject | computer model | |
| dc.subject | controlled study | |
| dc.subject | density functional theory | |
| dc.subject | drug design | |
| dc.subject | drug screening | |
| dc.subject | drug structure | |
| dc.subject | drug synthesis | |
| dc.subject | electrophilicity | |
| dc.subject | elemental analysis | |
| dc.title | Synthesis, Theoretical, in Silico and in Vitro Biological Evaluation Studies of New Thiosemicarbazones as Enzyme Inhibitors | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 13 | |
| rdl.department | Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, 24002, Erzincan, Turkey. | |
| rdl.oa.status | open | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | PUBMED |
